- Home
- SABS vs HHS Comparison
SABS vs HHS Comparison
Compare SABS & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- HHS
- Stock Information
- Founded
- SABS 2014
- HHS 1923
- Country
- SABS United States
- HHS United States
- Employees
- SABS N/A
- HHS N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- SABS Health Care
- HHS Consumer Discretionary
- Exchange
- SABS Nasdaq
- HHS Nasdaq
- Market Cap
- SABS 31.2M
- HHS 26.9M
- IPO Year
- SABS N/A
- HHS N/A
- Fundamental
- Price
- SABS $4.09
- HHS $3.17
- Analyst Decision
- SABS Strong Buy
- HHS
- Analyst Count
- SABS 3
- HHS 0
- Target Price
- SABS $9.00
- HHS N/A
- AVG Volume (30 Days)
- SABS 203.1K
- HHS 17.8K
- Earning Date
- SABS 11-13-2025
- HHS 11-10-2025
- Dividend Yield
- SABS N/A
- HHS N/A
- EPS Growth
- SABS N/A
- HHS N/A
- EPS
- SABS N/A
- HHS N/A
- Revenue
- SABS $114,698.00
- HHS $166,841,000.00
- Revenue This Year
- SABS N/A
- HHS $6.54
- Revenue Next Year
- SABS N/A
- HHS N/A
- P/E Ratio
- SABS N/A
- HHS N/A
- Revenue Growth
- SABS N/A
- HHS N/A
- 52 Week Low
- SABS $1.00
- HHS $2.33
- 52 Week High
- SABS $6.60
- HHS $6.20
- Technical
- Relative Strength Index (RSI)
- SABS 71.11
- HHS 58.07
- Support Level
- SABS $3.68
- HHS $2.73
- Resistance Level
- SABS $4.15
- HHS $2.87
- Average True Range (ATR)
- SABS 0.31
- HHS 0.14
- MACD
- SABS 0.04
- HHS 0.08
- Stochastic Oscillator
- SABS 93.18
- HHS 100.00
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.